- This position will be complementary to DuRoss’ new role as president of cell and gene therapies for CSafe Global, a Frazier portfolio company
- Prior to joining Frazier and CSafe Global, she was the co-founder and CEO of Vineti
- Founded in 1991, Frazier Healthcare Partners has raised over $7 billion in total capital
Frazier Healthcare Partners, a healthcare-focused private equity firm, has named Amy DuRoss as a senior advisor for its growth buyout team.
